Agios Pharmaceuticals
AGIO
#5171
Rank
C$2.35 B
Marketcap
C$39.53
Share price
0.90%
Change (1 day)
-5.21%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -C$0.66 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are C$66.04 Million. In 2025 the company made an earning of -C$0.66 Billion a decrease over its 2024 earnings that were of -C$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.66 Billion0.32%
2025 -C$0.66 Billion10.9%
2024 -C$0.59 Billion8.75%
2023 -C$0.55 Billion0.63%
2022 -C$0.54 Billion2.81%
2021 -C$0.53 Billion10.58%
2020 -C$0.48 Billion-18.41%
2019 -C$0.59 Billion15.72%
2018 -C$0.51 Billion12.99%
2017 -C$0.45 Billion59.61%
2016 -C$0.28 Billion69.32%
2015 -C$0.17 Billion119.28%
2014 -C$74.87 Million39.22%
2013 -C$53.78 Million69.1%
2012 -C$31.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.64 B-2,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.04 B-6,645.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.84 B-2,205.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-C$0.2 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.38 B-310.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.53 B-181.09%๐Ÿ‡บ๐Ÿ‡ธ USA